| Literature DB >> 33572859 |
David W Hawman1, Kimberly Meade-White1, Shanna Leventhal1, Aaron Carmody2, Elaine Haddock1, Kim Hasenkrug3, Heinz Feldmann1.
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne febrile illness with wide geographic distribution. In humans, the disease follows infection by the Crimean-Congo hemorrhagic fever virus (CCHFV) and begins as flu-like symptoms that can rapidly progress to hemorrhaging and death. Case fatality rates can be as high as 30%. An important gap in our understanding of CCHF are the host immune responses necessary to control the infection. A better understanding of these responses is needed to direct therapeutic strategies to limit the often-severe morbidity and mortality seen in humans. In this report, we have utilized a mouse model in which mice develop severe disease but ultimately recover. T-cells were robustly activated, differentiated to produce antiviral cytokines, and were critical for survival following CCHFV infection. We further identified a key role for interferon gamma (IFNγ) in survival following CCHFV infection. These results significantly improve our understanding of the host adaptive immune response to severe CCHFV infection.Entities:
Keywords: CCHFV; Crimean-Congo hemorrhagic fever; IFNγ; T-cells; mouse model
Year: 2021 PMID: 33572859 PMCID: PMC7912317 DOI: 10.3390/microorganisms9020279
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607